Specifically, dysregulation of AS has been shown to affect the expression of genes involved in key processes such as synaptic function, neuroinflammation, and tau protein metabolism, which are all critical components of AD pathology (Ishunina, 2021). This evidence concerns the gene MAPT and Alzheimer disease.